Company news
Well Lead Medical Co Ltd Class A (SSE:603309) news
Well Lead Medical Co Ltd Class A news releases on 6ix. Latest, Sep 17, 2026: "Well Lead Medical Co., Ltd."Announcement on Supplemental Pledge of Shares Held…
Press releases & updates
"Well Lead Medical Co., Ltd."Announcement on Supplemental Pledge of Shares Held by Shareholder
September 16, 2026
"Well Lead Medical Co., Ltd."Announcement on Resolutions of the 1st Meeting of the 6th Board of Directors
August 17, 2026
"Well Lead Medical Co., Ltd."Semi-annual Report for 2026
July 30, 2026
Announcement on Obtaining Class II Medical Device Registration Certificate for the Company's Product
June 17, 2026
Announcement on Implementation of Dividend Distribution for 2025
May 21, 2026
Announcement on Resolutions of the 2025 Annual General Meeting
May 13, 2026
Announcement on Release of Pledge and Re-pledge of Shareholder's Shares
April 23, 2026
Report for Q1 2026
April 22, 2026
Announcement on Change of Sponsor Representative for Continuous Supervision
March 27, 2026
Announcement on Extension of Share Pledge by Controlling Shareholders
February 25, 2026
Announcement on Obtaining Certification by EU MDR for Product
February 4, 2026
Announcement on Estimated Daily Related Party Transactions in 2026
January 9, 2026
Announcement on the Inclusion of the Wholly-owned Subsidiary’s Products in the List of “Hainan Innovative Drug and Medical Device Product Catalog"
January 8, 2026
Earnings Preannouncement for 2025
January 7, 2026
Announcement on Release of Pledge of Partial Shares of Controlling Shareholders
December 31, 2025
Announcement on Implementation of Dividend Distribution for Q3 2025
December 30, 2025
Announcement on Pledge of Partial Shares of Controlling Shareholder
December 18, 2025
Announcement on Completing Industrial and Commercial Change Registration
December 12, 2025
Announcement on Resolutions of the 2nd Extraordinary General Meeting in 2025
December 11, 2025
Notice on Convening the 2nd Extraordinary General Meeting in 2025
November 25, 2025
Announcement on the Inclusion of the Company’s Products in the "Guangzhou Innovative Drug and Medical Device Product Catalog"
October 29, 2025
Announcement on Convening the Q3 2025 Performance Briefing
October 20, 2025
Announcement on Implementation of Repurchase and Cancellation of Equity Incentive Restricted Stocks
October 17, 2025
Announcement on Pledge and Release of Pledge of Partial Shares of Shareholder
October 13, 2025
Announcement on Obtaining Class II Medical Device Registration Certificate for the Wholly-owned Subsidiary's Product
September 25, 2025
Announcement on Obtaining Class II Medical Device Registration Certificate for the Subsidiary's Product
September 4, 2025
Announcement on Resignation of Non-independent Director and Election of Employee Director
August 18, 2025
Announcement on Resolutions of the 1st Extraordinary General Meeting in 2025
August 15, 2025
Announcement on Progress in Participation in the Establishment of Industrial Investment Fund
August 12, 2025
Announcement on Resolutions of the 16th Meeting of the 5th Board of Directors
July 30, 2025
Announcement on Progress in Participating in the Establishment of Industrial Investment Fund
June 26, 2025
Announcement on Participating in the Establishment of Industrial Investment Fund
June 23, 2025
Announcement on Obtaining Certification from Health Canada for the Company's Products
June 16, 2025
Announcement on Completion of Use and Cancellation of Special Account for Raised Funds
May 30, 2025
Announcement on Implementation of Dividend Distribution for 2024
May 22, 2025
Announcement on Outward Investment in Establishing an Overseas Sub-subsidiary and Related Party Transactions
May 21, 2025
Announcement on Holding Subsidiary Obtaining Business License for Medical Devices
May 20, 2025
Announcement on Resolution of the 2024 Annual General Meeting
May 15, 2025
Announcement on Obtaining Certification by EU MDR for Product of Holding Subsidiary
May 6, 2025
Announcement on Holding Subsidiary Obtaining Medical Device Business Registration Certificate
April 28, 2025
Announcement on Convening Performance Briefing for 2024 and Q1 2025
April 24, 2025
Announcement on Registration Approval of Products by FDA in the United States
March 6, 2025
Announcement on the Re-certification of Subsidiary as High-Tech Enterprise
February 27, 2025
Announcement on the Re-certification of the Wholly-owned Subsidiary as High-Tech Enterprise
February 19, 2025
Announcement on Resolutions of the 13th Meeting of the 5th Board of Directors
January 10, 2025